This morning, MSK physician-scientist shared research during the Opening Plenary Session at #AACR26 about how cancer cells escape targeted therapy by changing identity.
@AACR

Key conclusions:

Adenocarcinomas with RB1 loss are at risk ("primed") to undergo NE lineage